Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease breast cancer
Phenotype C0011570|depression
Sentences 55
PubMedID- 21054923 Sexual abuse in childhood and postoperative depression in women with breast cancer who opt for immediate reconstruction after mastectomy.
PubMedID- 23725190 Prevalence of depression in breast cancer survivors: a systematic review of observational studies.
PubMedID- 24077731 According to the prisma guidelines, we conducted a systematic review of randomized, controlled clinical trials and open label prospective studies on antidepressants effects on depression in women with breast cancer up to january 14, 2013.
PubMedID- 20385344 Several psychotherapeutic modalities offer relief of the symptoms and syndromes of depression in breast cancer.
PubMedID- 22639749 In some studies, it has been stated that breast cancer metastasis is associated with depression and overall quality of life, and it has also been reported that the recurrence of breast cancer strongly lowered the quality of life of patients, and even their guardians.6,7 this appears to be due to a fear of additional metastasis as well as the burden of additional treatments after metastasis.
PubMedID- 26445699 1996), whereas a helplessness/hopelessness stress-coping style is associated with depression in patients with breast cancer (schou et al.
PubMedID- 25954147 (2013) investigated fatigue and depression symptoms in patients with breast cancer.
PubMedID- 19458878 Materials and methods: this was a prospective study of anxiety and depression in breast cancer patients.
PubMedID- 26453348 These results suggest that ipt is a promising treatment for depression in women with breast cancer.
PubMedID- 20602189 A randomized trial of bupropion vs. other antidepressants, both at standard and lower doses (similar to those used for hot flash management), would provide valuable information and offer options for breast cancer patients with both depression and sexual dysfunction.
PubMedID- 25761086 Trajectories of distress, anxiety, and depression among women with breast cancer: looking beyond the mean.
PubMedID- 24362868 Treatment of depression in patients with breast cancer: a critical review.
PubMedID- 24007891 This case highlights the incidence of depression in persons with breast cancer, examines the controversy of tamoxifen-induced depression, and evaluates antidepressant considerations regarding potentially efficacy-reducing cytochrome p450 2d6 drug interactions with tamoxifen.
PubMedID- 23646866 Methods: sixty-two breast cancer patients diagnosed with major depression were randomly assigned to gcbt group (n = 31) or a waiting list control group provided with an educational booklet (n = 31).
PubMedID- 23041586 Conclusions: exercise intervention improved fatigue, depression, and qol in patients with breast cancer receiving adjuvant therapy.
PubMedID- 23865135 Objective: to investigate the prevalence of depression in women with breast cancer and relate it to their health-related quality of life.
PubMedID- 26064177 Moreover, we found that the anxiety, depression, and stress levels of breast cancer patients could be reduced after a single tlp session.
PubMedID- 24337537 Some evidence suggests that a decrease in depression in patients with metastatic breast cancer is associated with lower mortality [42].
PubMedID- 26009671 Aim: to compare the effects of yoga program with supportive therapy on self-reported symptoms of depression in breast cancer patients undergoing conventional treatment.
PubMedID- 26508964 The individual effects of bdnf promoter methylation percentages on depression in patients with breast cancer at the two evaluations were tested using multivariate logistic regression models after adjustment for those sociodemographic and clinical characteristics that were significantly associated with depression at 1 week or 1 year after breast surgery (p<0.05).
PubMedID- 26035180 breast cancer patients with a depression diagnosis also had lower mortality (or=0.69, 95% ci: 0.52-0.89) compared with those without a depression diagnosis, but there was no significant difference in mortality among those with and without anxiety diagnoses.
PubMedID- 22888085 depression in breast cancer patients and survivors is related to negative disease outcomes and worse quality of life.
PubMedID- 23512358 Predictors of depression in breast cancer patients treated with radiation: role of prior chemotherapy and nuclear factor kappa b.
PubMedID- 25960844 Effectiveness of group training based on acceptance and commitment therapy on anxiety and depression of women with breast cancer.
PubMedID- 23217093 Methods/design: eligible breast cancer patients with comorbid depression are assigned to short-term psychodynamic psychotherapy (up to 20 + 5 sessions) or to treatment as usual (augmented by recommendation for counseling center and physician information).
PubMedID- 25684491 Associations among physical activity, comorbidity, functional capacity, peripheral muscle strength and depression in breast cancer survivors.
PubMedID- 23604452 Icf, quality of life, and depression in breast cancer: perceived disability in disease-free women 6 months after mastectomy.
PubMedID- 20142325 The prevalence of depression in women with early breast cancer is roughly twice that of the general female population and is particularly high around the time of diagnosis.39 in our study, 30% of women who started tamoxifen treatment also received antidepressants, and paroxetine was the most commonly used ssri.
PubMedID- 23788906 The association of breast cancer with anxiety and depression has been supported in previous studies [3–6].
PubMedID- 24817896 Arts therapies for anxiety, depression, and quality of life in breast cancer patients: a systematic review and meta-analysis.
PubMedID- 24243809 Eysenck personality questionnaire revised psychoticism predicts motivational-somatic symptoms of depression in breast cancer survivors.
PubMedID- 22699176 Further studies are needed to identify the effect on emotions such as anxiety and depression for women with breast cancer with above average levels of anxiety and depression.
PubMedID- 25287728 Methods: seventy-seven breast cancer patients with comorbid depression were evaluated with the hamilton depression rating scale (hamd), the clinical global impression-severity of illness (cgi-s) for depression, and the functional assessment of cancer therapy-breast (fact-b).
PubMedID- 20814770 Estimation of anxiety and depression in patients with early stage breast cancer before and after radiation therapy.
PubMedID- 26516588 Now established agents such as trastuzumab (herceptin), a monoclonal antibody targeted against mutant forms of the her2/neu receptor licensed for use against some forms of breast cancer, are associated with cardiac depression and an increase in adverse outcomes when combined with other anticancer agents with known cardiotoxicity risks (seidman et al.
PubMedID- 23731173 Exercise programmes are safe and effective on quality of life and depression in breast cancer patients whose treatments are complete.
PubMedID- 24347520 Patients and methods: in a multicenter prospective trial, 157 breast cancer patients with comorbid depression were randomized to either individual stpp (intervention group, n=78) or 'treatment as usual' (control group, tau, n=79).
PubMedID- 25780852 Evaluation of symptoms of anxiety and depression in women with breast cancer after breast amputation or conservation treated with adjuvant chemotherapy.
PubMedID- 25921125 Background: whether depression causes increased risk of the development of breast cancer has long been debated.
PubMedID- 21462281 Conclusion: our study suggests a high rate of associated depression among patients with breast cancer in our environment.
PubMedID- 25377647 Here, we review the prevalence and treatment of anxiety and depression among patients with breast cancer.
PubMedID- 25788991 In a cohort study investigating breast cancer outcomes in patients with depression, only 51% of the study group (breast cancer patients with depression) accepted and commenced chemotherapy, compared with 92% of the control group (breast cancer patients without depression) (4).
PubMedID- 21567239 Sleep duration among breast cancer survivors correlates with fatigue, depression, and health-related quality of life (hrqol); however, this has not been studied longitudinally.
PubMedID- 25674442 The use of selected serotonin reuptake inhibitors (ssri’s), anti-depressives used to treat both hot flashes and depression in women with breast cancer, has recently been the focus of controversy.
PubMedID- 25201115 Cancer-related fatigue and depression in breast cancer patients postchemotherapy: different associations with optimism and stress appraisals.
PubMedID- 23124416 Influence of age, performance status, cancer activity, and il-6 on anxiety and depression in patients with metastatic breast cancer.
PubMedID- 22409643 Anxiety and depression in breast cancer survivors of different sexual orientations.
PubMedID- 23967823 However, due to a few of studies (the number is less than or equal to 3) separately reporting the or for depression and anxiety in patients with breast cancer, lung cancer, liver cancer, the subgroup comparison of depression and anxiety in different types of cancer patients were not analyzed.
PubMedID- 25111433 Although several outcome studies have explored the utility of psychotherapy for breast cancer patients with subsyndromal depression symptoms, only a few clinical trials have explored the efficacy of behavior therapy for patients with well-diagnosed mdd.
PubMedID- 25543421 [efficacy on depression in breast cancer treated with acupuncture and auricular acupressure].

Page: 1 2